Ejenta

A one-sentence summary

Ejenta is an intelligent, connected care platform designed for medical institutions, insurers, and research projects; it collects data continuously through health devices, environmental sensors, electronic health records, and patient applications, thereby enabling teams to carry out remote monitoring, detect abnormalities, provide personalized support, and coordinate care efforts.

Tool Introduction

Ejenta was developed by Ejenta, Inc. in San Francisco, USA. Its focus is not on general health chatbots available to individuals, but rather on remote health management solutions designed for use by healthcare providers, insurance companies, or research projects.

The platform uses intelligent agents to learn about individual data and daily patterns; it generates alerts when new measurement values deviate from the baseline, and presents the relevant information to the patient and the care team. The actual monitoring parameters, thresholds, devices, intervention rules, and accounts are usually configured by the collaborating organizations.

Product composition

Main functions

Connect health devices and sensors

The Impact app can connect to supported weight scales, blood pressure monitors, and blood glucose meters, as well as integrate with Apple Health data. Institutional projects can also combine wearable devices, environmental sensors, and other IoT data; the specific list of devices must be confirmed prior to deployment.

Integrate electronic health records

The public objectives of Ejenta include learning about a patient’s condition from electronic health records and connected devices, thereby integrating continuous home-based measurements with existing clinical data within the same care framework. It is up to the purchaser to determine, through a technical assessment, whether a particular recording system, exchange standard, or data field is supported.

Individual baseline learning

Smart agents learn individual patterns based on the data that continues to be supplied, rather than applying the same fixed threshold to everyone. An individualized baseline can help teams identify relative changes, but it is still affected by device errors, missing data, and model biases.

Detection of abnormalities and prediction of health deterioration

The platform is used to detect abnormalities and identify potential deterioration in health conditions in advance, providing the care team with clues for further assessment. Predictions are auxiliary information only; they do not constitute diagnoses, treatment decisions, or alerts from medical devices.

Patient reminders and behavioral support

Smart agents can interact with users, providing reminders and support regarding measurements, plan execution, and healthy behaviors. The content of these reminders, their frequency, the channels through which they are delivered, and the rules for upgrading them need to be determined based on the project objectives and the preferences of the patients.

Collaboration among the nursing team

The system converts fragmented family data into actionable information, and it keeps caregivers, patients, and project teams in touch. The organization still needs to determine who should view the signals, how quickly a response is required, when to contact the patient, and when to hand the case over to clinical staff.

Local intelligent agent

In aerospace medical research for 2025, Ejenta combines medical devices and environmental sensors with intelligent agents that operate in local aerospace environments. This approach is focused on autonomous medical systems under conditions of communication delays; it does not involve diagnostic capabilities that are available to the public.

Input and output

Remote care workflow

1. Medical institutions or insurers first determine the target population, care objectives, inclusion criteria, and clinical responsibilities.
2. The project team selects the supported devices, data fields, patient applications, and the scope of electronic health record integration.
3. The organization creates or assigns Ejenta accounts and explains to the members how the data will be used, how communication will take place, and what procedures should be followed in emergency situations.
4. The patient installs the Impact app, logs in to their account, and follows the instructions to connect a scale, blood pressure monitor, glucose meter, or Apple Health.
5. The devices and applications continuously send authorized data, and the platform establishes individual baselines as well as implements the monitoring logic specified for each project.
6. When deviations, missing measurements, or risk signals occur, the system displays information to designated personnel or initiates a communication process.
7. Nursing staff review the medical history, initial readings, and the patient’s condition to decide on whether to give reminders, schedule follow-ups, refer the patient to another specialist, or take other actions.
8. The project team continuously reviews false positives, false negatives, response times, patient engagement, equipment failures, and clinical outcomes.

Impact app usage guide

Start using it.

1. Confirm that you have been included in a medical facility, insurance plan, or research project and that you possess a valid Ejenta account.
2. Install Impact by Ejenta on compatible Apple devices; do not confuse it with third-party apps that have similar names.
3. Read the project details, the terms of the mobile application, and the privacy policy to understand the scope of data collection and the communication channels used.
4. Log in using the credentials provided by the organization, and set up a secure device lock as well as an account password.
5. Pair the supported weight scales, blood pressure monitors, or blood glucose meters according to the project instructions.
6. If you want to use Apple Health data, grant permissions only for the categories that the app truly needs.
7. Complete a test measurement to verify that the values, time, and device identity are synchronized correctly.
8. Find out who to contact in case of abnormal readings, technical failures, and medical emergencies.

Daily measurement and verification

1. Measurements are taken under similar time and project requirements to minimize differences in posture, diet, and equipment.
2. Before submitting, check whether the readings are significantly affected by errors related to the cuff, test strips, scale surface, or connections.
3. Check the records and reminders within the app; if any are missing or duplicated, resync them promptly.
4. Upon receiving the reminder, act in accordance with the care plan; do not modify the prescription on your own based on the suggestions provided by the algorithm.
5. Report symptoms, equipment issues, and abnormalities through the message or telephone channels specified by the project.
6. In case of a medical emergency, use the local emergency services directly, without waiting for a response via the app.

Institutional Deployment Tutorial

Carry out small-scale pilot projects

1. Select a remote monitoring scenario with clear clinical boundaries, defined responsibilities, and the possibility for manual verification.
2. Define the inclusion and exclusion criteria, required equipment, measurement frequency, abnormality thresholds, and upgrade pathways.
3. Conduct assessments of privacy, security, clinical risks, accessibility, and informed patient communication.
4. Confirm the integrated design of electronic health records, identity management, device logistics, messaging, and care queues.
5. Representative patients are used to conduct tests for device pairing, network disconnection, incorrect readings, and repeated alarms.
6. The pilot programs are evaluated based on accuracy, response time, patient burden, clinical workload, and cost.
7. Only after the manual processes become stable and meet the prescribed standards is it possible to expand the scope of the population involved and the level of automation.

Design safe exception responses

1. Classify device quality issues, general reminders, clinical reviews, and emergency situations into different priority levels.
2. Assign a receiving role, response time limit, backup personnel, and upgrade path for each type of signal.
3. Allow the staff to see the original measurements, time, recent trends, and the necessary clinical background at the same time.
4. Set suppression, merging, and secondary confirmation for continuous, repeated, or conflicting signals.
5. Retain audit records of the manual coverage applied, the reasons for the handling, the outcomes of the communications, and the final conclusions.
6. Regularly assess false positives, false negatives, and differences in performance across different populations using the confirmed events.

Brahms intelligent agent technology

Brahms Agent Language is a agent-oriented language used for building intelligent distributed systems, and it falls within the framework of belief-desire-intention and cognition. Agents can perceive their environment, maintain beliefs, carry out activities, and exchange messages with other agents.

Brahms is related to the Ejenta commercial health platform, but the two are not identical; Brahms’ development environment is designed for research and intelligent agent applications, while Impact is intended for patient applications in institutional settings.

Apply for a Brahms trial version

1. First, determine whether the project involves academic modeling, intelligent agent prototypes, or a commercial system intended for production.
2. Submit a license request through the Ejenta developer portal, providing accurate details regarding the organization, purpose, and environment.
3. Read the 90-day trial license to understand the limitations such as single-machine use, non-production use, and the fact that it cannot be transferred or further licensed.
4. Install the development environment on a separate evaluation computer; do not use trial software in production services.
5. Use small proxy models to verify belief, activity, message, and environment perception logic.
6. Decide to stop using it, uninstall it, or negotiate a production license with Ejenta before the trial period expires.

NASA’s boundaries for technical and research cooperation

The Ejenta official website states that its platform is based on intelligent agent technology licensed for use by NASA, with such agents having been used for a long time in the mission control operations of the International Space Station. The website also mentions that there exists a reciprocal licensing agreement between Ejenta and NASA related to Brahms.

In 2025, efforts in space medicine involved conducting tests for clinical decision support in collaboration with NASA’s AI team for human research and TRISH. The prototypes did not make use of any personal health information, nor were they used to make actual decisions; at that time, NASA was still exploring the limits of its capabilities and the best practices to follow.

Which users are it suitable for

• Medical institutions: To organize family-based device monitoring, care cohorts, and follow-up procedures for specific populations.
• Health insurance agencies: Implement member-centered care and programs for managing high-risk populations.
• Nursing management team: Converts continuous measurements and abnormal signals into actionable tasks for manual review.
• Academic Medical Center: Researching remote monitoring, patient participation, and intelligent agent-assisted care.
• Government and aerospace research teams: Evaluating the support provided by local health data in environments with limited communication capabilities.
• Patients who have joined the program: Connect their devices via the Impact app and submit their health information as scheduled.
• Multi-agent system developers: Apply for the Brahms license to conduct evaluations of cognitive agents and distributed systems.

Typical use cases

• People who require continuous monitoring, such as those with heart failure, can submit data on their weight and blood pressure from home.
• Upon detecting a deviation from the individual’s trend, the member is placed in the queue for review by nursing staff.
• Send reminders to patients regarding measurements, device usage, plan implementation, and follow-up.
• Combine data from connected devices with existing health records to reduce manual data compilation.
• Assess the impact of remote monitoring programs on nursing workload, engagement, and overall costs.
• Simulate the collaboration between local intelligent agents and medical devices sowie environmental sensors in a research environment.
• Use Brahms to build agent models that can create perceivable environments, maintain beliefs, and communicate with each other.

Product advantages

• Integrate patient applications, connected devices, health records, and care coordination under the same framework of remote monitoring.
• Individual baseline learning can complement traditional monitoring methods that rely solely on fixed thresholds.
• Smart agents not only generate analyses but can also be used for reminders, communication, and advancing workflows.
• Impact supports common home health monitoring devices and the Apple Health ecosystem.
• Brahms offers specialized development pathways for multi-agent and cognitive architectures.
• NASA’s mission control and space medicine research provide a technical foundation for complex remote environments.
• Enterprise applications can be designed around specific groups of people, devices, and care processes, rather than being generic solutions intended for everyone.

Usage restrictions and precautions

• Ejenta is not a licensed healthcare provider, and the platform and applications cannot replace a doctor’s advice, diagnosis, or treatment.
• Although Impact can be downloaded for free, an Ejenta account is required, and it is usually necessary to first join an institutional project.
• The official website does not disclose the standard packages, the cost per patient, the cost of equipment, or the pricing for implementation.
• Device readings can be affected by wearing style, posture, calibration, battery level, connection, and patient manipulation.
• Predictions and anomaly signals may suffer from false positives, false negatives, or population bias, and must be reviewed by qualified personnel.
• The application currently only displays in English; it cannot be assumed that a Chinese interface is available.
• Regular application messages, emails, and text messages are not suitable for dealing with medical emergencies.
• The mobility clause permits the use of unencrypted emails or text messages in certain care-related communications; organizations should assess the risk of sensitive information being exposed.
• Clinical decision support in aerospace medicine is still in the research and testing phase, and cannot be used as a promotional feature for commercial clinical applications.
• The trial license for Brahms is intended only for evaluation purposes; it cannot be used for production, external services, or to conclude that the software is open source.
• The privacy policy came into effect in 2016, and the terms related to mobile devices were last updated in 2020; purchasers should request the most up-to-date information on security and privacy matters.

Prices and Purchases

As of August 22, 2026, Ejenta’s official website does not disclose any fixed pricing for its remote monitoring platform, nor any prices based on the number of users or implementation costs. For corporate solutions, it is necessary to contact the company directly; a quote will be provided depending on factors such as the user base, devices involved, integration requirements, care processes, support needs, and the scope of research required.

The fact that the application can be downloaded for free does not mean that the equipment, nursing services, or institutional programs are also free. Before making a purchase, it is necessary to determine the total cost of hardware, logistics, patient support, integration, training, licensing, maintenance, and data export.

Enterprise quotation request form

1. Describe the target disease or population, the estimated number of participants, the region, and the project duration.
2. List the devices that need to be connected, Apple Health fields, and electronic health record systems.
3. Determine who is responsible for account activation, device delivery, patient training, and technical support.
4. Separate costs are required for platform licensing, per member, devices, implementation, integration, and ongoing support.
5. Ask whether there are additional fees for abnormal rule settings, model configurations, manual queues, and custom workflows.
6. Confirm service availability, support hours, failure escalation, and disaster recovery commitments.
7. Agree on the export of data, its deletion, the recovery of devices, and the suspension of accounts after the contract ends.

Supported platforms

The Impact app store currently features an English interface, has a size of around 218.1 MB, and requires users to have an Ejenta account. The indication of free download in the app store refers only to the cost of installation; it does not mean that anyone can register and use it without any issues.

Privacy, Security, and Compliance

Ejenta handles health information, contact details, account credentials, device data, communication content, and usage records. The privacy label on Impact’s app store indicates that data associated with an individual’s identity may include health information, name, email address, phone number, and interactions with the product.

The official privacy policy classifies certain health information as protected health information and mentions the rights under the U.S. Health Information Privacy Framework. Based solely on this policy, it is not possible to conclude that every service, every customer, or all data streams automatically comply with a particular regulation.

• A privacy policy may cover names, email addresses, phone numbers, account details, addresses, dates of birth, physical data, test results, as well as information regarding medical providers and insurance.
• The service can retrieve data from third-party applications, websites, and devices authorized by the user.
• The mobile terms cover device identification, phone status, location, Bluetooth, data from other applications, and permissions for network services.
• Officials state that personal information will not be rented or sold, but necessary information may be disclosed to service providers for the purposes of providing services, conducting research, marketing, data processing, and usage measurement.
• Some service providers may be located in other countries, and the organization needs to identify the actual sub-processors and the cross-border pathways.
• Users can request an update to their information through their account or via the support channels; the old policy stated that requests for access would be addressed within 30 days.
• Text messages and some emails may not be encrypted; therefore, unnecessary sensitive health details should not be sent via such channels.
• Medical institutions should request information on the current security architecture, audit reports, agreements with business partners, data retention and deletion policies, as well as procedures for responding to incidents.
• When terminating a project, it is necessary to verify that the data in the main system, backups, device caches, analysis results, and third-party systems has been processed as agreed.

Steps for safety assessment of medical institutions

1. Map the complete data flow between patients, devices, applications, the Ejenta platform, health records, and caregivers.
2. Distinguish between personal information, protected health information, device telemetry, communications, and de-identified research data.
3. Request the current privacy policy, mobile terms, sub-processors, data locations, and information on security controls.
4. Verify transmission and storage encryption, key management, authentication, principle of least privilege, and audit logs.
5. Procedures for disabling test accounts, patients withdrawing from the program, devices being lost, incorrect data, and responding to security incidents.
6. The contract should specify the roles of the data, the retention period, proof of deletion, notification timelines, and the boundaries of responsibilities.

APIs, SDKs, GitHub, and open-source status

As of the date of verification, Ejenta’s official website does not provide an API catalog for modern health platforms intended for use by the public, no information on pricing for these APIs, nor a developer console through which one can register directly. The capabilities related to enterprise integration need to be determined during sales and technical evaluations.

The Brahms development environment includes developer licenses and historical documentation, but it is not an open-source SDK. The trial agreement restricts modification, redistribution, reverse engineering, and use in production; therefore, the Ejenta platform, Impact applications, or Brahms cannot be classified as open source.

Basic information

Recommendation score

Its rating is 4.1 out of 5 points. Ejenta connects home devices, patient applications, health records, personalized monitoring, and care workflows; it is suitable for organizations that possess strong capabilities in clinical management and project execution.

The main shortcomings are the lack of publicly available pricing information, suitable interfaces for health-related platforms, an appropriate deployment architecture, as well as insufficient security measures. Moreover, Impact is not a consumer application that can be used immediately after individual registration. Medical procurement should first involve small-scale trials to assess the reliability of the equipment, the burden on staff, any biases in the models, and the actual outcomes of care provided.

Frequently Asked Questions

What is Ejenta?

Ejenta is an AI-based platform for remote health monitoring and connected care, designed for organizations; it transforms home devices, health records, and patient communications into information that can be reviewed by care teams.

Can ordinary users use it directly?

It is generally not possible to register for the full service on one’s own. The Impact application requires an existing Ejenta account, which is usually provided by partnering medical institutions, insurance plans, or research projects.

Is the Impact app free?

The app store indicates that the download is free, but this merely means there is no cost for downloading it. Whether there are fees associated with devices, care services, institutional services, and platform licenses depends on the programs to which the user subscribes.

Which health devices are supported?

The official app description specifies the supported weight scales, blood pressure monitors, and blood glucose meters, as well as the ability to connect to Apple Health. The specific brands, models, and availability in different regions must be confirmed by the project team.

Can the agent automatically diagnose diseases?

It shouldn’t be understood in that way. The platform can detect abnormalities and predict risks, but the authorities have made it clear that it does not provide medical advice, diagnoses, or treatments; the final decisions should be made by qualified medical professionals.

Can it handle medical emergencies?

Impact is not an emergency response service. In the event of a suspected medical emergency, you should contact the local emergency services immediately, without waiting for apps, text messages, or care alerts.

How does Ejenta charge?

The enterprise platform does not have fixed standard prices; it is necessary to contact sales for a customized quote. The quote is usually determined based on factors such as the number of users, the equipment used, integration requirements, implementation needs, support services, and the duration of the project.

Is Chinese supported?

The current Impact app store page is available only in English; no Chinese version has been identified. Before deploying it to the Chinese-speaking audience, the organization should test the translations, readability, and patient support features.

Are APIs provided?

The official website does not provide a publicly available list of APIs for health platforms that can be registered independently, nor any information regarding pricing. If companies wish to connect to electronic health records, identity management systems, care delivery systems, or device platforms, they must determine the interfaces, authentication methods, usage limits, and level of support at the time of making the purchase.

Is Ejenta open source?

It is not open source. The Ejenta platform and Impact application are commercial, closed-source products; although Brahms comes with developer documentation and a trial license, the trial version is also subject to strict proprietary licensing restrictions.

What is Brahms?

Brahms is an agent-oriented artificial intelligence language used to create intelligent distributed systems that are capable of perceiving, maintaining beliefs, carrying out tasks, and communicating with one another. It is related to the Ejenta health platform, but it is not part of the Impact patient application.

Can Brahms be used commercially for trial purposes?

No. The public trial license is valid for 90 days and is intended only for single-machine testing and evaluation; it is not allowed for use in production or for providing services to third parties. Commercial use requires separate authorization.

Has NASA certified the Ejenta medical products?

It cannot be expressed in that way. Ejenta benefits from NASA’s intelligent agent technology and related collaborative efforts; clinical decision support in the field of aerospace medicine is still under research and testing, and this does not mean that NASA has certified all of its medical products.

How will patient data be processed?

The service may handle health information, contact details, device and application data, as well as communication and usage records; it may also share necessary data with trusted service providers. Organizations and patients should consult the current contracts, project guidelines, and privacy documents to understand the actual purposes of data processing, as well as the rules regarding its storage and deletion.

Summary

Ejenta is better understood as an institutional-level infrastructure for connected care, rather than a standalone health application intended for the general public. It transforms home-based measurements into a continuous monitoring and coordinated care process, through Impact, connected devices, health records, and intelligent agents.

When choosing Ejenta, clinical responsibilities, equipment reliability, patient accessibility, privacy and security, interface capabilities, and the total cost of acquisition should all be considered within the same evaluation framework. The technical expertise associated with NASA and Brahms is notable, but research prototypes, licensed development environments, and formal medical services need to be assessed separately.